Peregrine Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,200
Closed -$39.3K 335
2023
Q4
$39.3K Sell
3,200
-338,639
-99% -$3.18M ﹤0.01% 285
2023
Q3
$5.12M Sell
341,839
-21,235
-6% -$442K 0.15% 228
2023
Q2
$11.8M Buy
363,074
+32,055
+10% +$1.17M 0.32% 89
2023
Q1
$13M Buy
331,019
+64,272
+24% +$3.14M 0.37% 69
2022
Q4
$14.1M Sell
266,747
-16,283
-6% -$793K 0.44% 55
2022
Q3
$12.7M Sell
283,030
-128,994
-31% -$5.55M 0.41% 66
2022
Q2
$15M Sell
412,024
-3,441
-0.8% -$125K 0.45% 55
2022
Q1
$17.2M Buy
415,465
+10,698
+3% +$377K 0.41% 54
2021
Q4
$17.2M Buy
404,767
+79,169
+24% +$3.96M 0.35% 73
2021
Q3
$17.9M Sell
325,598
-101,604
-24% -$5.32M 0.37% 61
2021
Q2
$20.4M Buy
427,202
+52,349
+14% +$2.67M 0.37% 69
2021
Q1
$19M Buy
374,853
+21,262
+6% +$1.18M 0.35% 100
2020
Q4
$22.3M Buy
353,591
+18,752
+6% +$1.16M 0.42% 67
2020
Q3
$22.5M Sell
334,839
-171,224
-34% -$9.35M 0.6% 50
2020
Q2
$21.2M Sell
506,063
-49,063
-9% -$1.88M 0.6% 56
2020
Q1
$17.5M Buy
555,126
+115,029
+26% +$4.61M 0.63% 51
2019
Q4
$17.8M Buy
+440,097
New +$15.4M 0.45% 94

Other funds holding SILK

Peregrine Capital Management's SILK Position: Q1 2024 in Review

Peregrine Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2024, closing a stake of 3,200 shares — an estimated $39.3K sold.

Peregrine Capital Management first reported a position in SILK in Q4 2019 and held it in 17 quarters. The position peaked at $22.5M in Q3 2020. 154 funds tracked by Wall St. Rank hold SILK as of Q1 2024.

  • Peregrine Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Peregrine Capital Management sold 3,200 Silk Road Medical, Inc. Common Stock shares in Q1 2024, an estimated $39.3K.
  • Peregrine Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Peregrine Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $22.5M in Q3 2020.
  • 154 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2024.

Based on Peregrine Capital Management's 13F filing for Q1 2024, filed 26 Apr 2024.